ARK Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $495M | Buy |
|
|||||
|
2025
Q1 | $346M | Buy |
|
|||||
|
2024
Q4 | $353M | Buy |
|
|||||
|
2024
Q3 | $352M | Sell |
|
|||||
|
2024
Q2 | $420M | Sell |
|
|||||
|
2024
Q1 | $556M | Sell |
|
|||||
|
2023
Q4 | $534M | Buy |
|
|||||
|
2023
Q3 | $325M | Sell |
|
|||||
|
2023
Q2 | $412M | Sell |
|
|||||
|
2023
Q1 | $361M | Buy |
|
|||||
|
2022
Q4 | $318M | Sell |
|
|||||
|
2022
Q3 | $538M | Sell |
|
|||||
|
2022
Q2 | $565M | Buy |
|
|||||
|
2022
Q1 | $590M | Buy |
|
|||||
|
2021
Q4 | $689M | Buy |
|
|||||
|
2021
Q3 | $849M | Sell |
|
|||||
|
2021
Q2 | $1.26B | Sell |
|
|||||
|
2021
Q1 | $1.01B | Sell |
|
|||||
|
2020
Q4 | $1.59B | Buy |
|
|||||
|
2020
Q3 | $707M | Buy |
|
|||||
|
2020
Q2 | $476M | Buy |
|
|||||
|
2020
Q1 | $182M | Buy |
|
|||||
|
2019
Q4 | $180M | Buy |
|
|||||
|
2019
Q3 | $114M | Buy |
|
|||||
|
2019
Q2 | $128M | Buy |
|
|||||
|
2019
Q1 | $72.3M | Buy |
|
|||||
|
2018
Q4 | $37.9M | Sell |
|
|||||
|
2018
Q3 | $64.5M | Buy |
|
|||||
|
2018
Q2 | $27.4M | Buy |
|
|||||
|
2018
Q1 | $3.32M | Buy |
|
|||||
|
2017
Q4 | $737K | Buy |
|
|||||
|
2017
Q3 | $457K | Buy |
|
|||||
|
2017
Q2 | $206K | Buy |
|